Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
AstraZeneca
University of Wisconsin, Madison
Mayo Clinic
Merck Sharp & Dohme LLC
Neonc Technologies, Inc.
Replimune Inc.
Aulos Bioscience, Inc.
Ocellaris Pharma, Inc.
Sotio Biotech Inc.
Transgene
NeoImmuneTech
University of Arizona
Incyte Corporation
Marengo Therapeutics, Inc.
Fred Hutchinson Cancer Center
ImmunityBio, Inc.
Melanoma and Skin Cancer Trials Limited
Xencor, Inc.
Nektar Therapeutics
Kartos Therapeutics, Inc.
Ludwig Institute for Cancer Research
Incyte Corporation
Exicure, Inc.
Fred Hutchinson Cancer Center
Dana-Farber Cancer Institute
Fred Hutchinson Cancer Center